These analyses indicated that TNF/Mel/SM significantly increased tumour death compared to TNF/Mel alone (P = 0.0034, unpaired t‐test) (Fig 3C), in keeping with augmented therapy in this therapeutic cohort. Here, TNF is linked to neoplasm.